• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AZV
Click for more information
0.00% 6.5¢

AZURE HEALTHCARE LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Azure Healthcare Limited is a healthcare communication and clinical management solutions... Azure Healthcare Limited is a healthcare communication and clinical management solutions provider. The Company, through its subsidiary, Austco Communication Systems Pty Ltd., manufactures nurse call systems and clinical workflow solutions for hospitals and aged care facilities. The Company's Tacera is an Internet Protocol (IP)-based nurse call solution for healthcare facilities that provides plug-and-play functionality. Tacera's Voice over Internet Protocol (VoIP) interface enables voice communications between nursing staff and the patient, without the need for third party middleware. It also offers CellGuard for the custodial care market. CellGuard provides complete audio communication solutions, including officer duress, cell intercom, discrete monitoring, door intercom, background music distribution and public address announcements. It offers MediCom for the aged care market. The MediCom Nursecall System enables nurses to provide prompt responses to patients' calls at all times.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AZV Investor Relations Presentation25/03/19
AZV Forfeiture and Issue of Options and Appendix 3B20/03/19
AZV Azure HY19 Results Investor PresentationPRICE SENSITIVE27/02/19
AZV Azure HY19 Results ASX and Media ReleasePRICE SENSITIVE27/02/19
AZV Azure HY19 Appendix 4D and Interim Financial ReportPRICE SENSITIVE27/02/19
AZV Forfeiture of Options04/02/19
AZV Change of Director's Interest Notice - Glenning20/12/18
AZV Resignation of Company Secretary03/12/18
AZV Results of Meeting28/11/18
AZV CEO's Address to ShareholdersPRICE SENSITIVE28/11/18
AZV Chairman's Address to ShareholdersPRICE SENSITIVE28/11/18
AZV Market Update Impact of US Tariff ChangesPRICE SENSITIVE28/11/18
AZV Change of Director's Interest Notice - Astles23/11/18
AZV Notice of Annual General Meeting/Proxy Form26/10/18
AZV New Chief Financial Officer Joins Azure Healthcare22/10/18
AZV Appendix 4G - Key to disclosures28/09/18
AZV Full Year Statutory Accounts27/09/18
AZV Change in substantial holding14/09/18
AZV Ceasing to be a substantial holder13/09/18
AZV Change in substantial holding12/09/18
AZV Initial Director's Interest Notice10/09/18
AZV Investor presentation - 2018 ResultsPRICE SENSITIVE03/09/18
AZV New Director appointment31/08/18
AZV 2018 Financial year results29/08/18
AZV Preliminary Final ReportPRICE SENSITIVE29/08/18
AZV $1.9m new hospital project in Nth AmericaPRICE SENSITIVE16/08/18
AZV Agreement with Ideacom Mid-America Cements US positionPRICE SENSITIVE31/07/18
AZV Corporate Governance Statement20/06/18 download Created with Sketch. 464.58KB
AZV Change of auditors31/05/18 download Created with Sketch. 91.62KB
AZV New hospital project in Nth AmericaPRICE SENSITIVE29/05/18 download Created with Sketch. 77.66KB
AZV FY18 Half year shareholders presentation27/02/18
AZV Half Yearly Report and AccountsPRICE SENSITIVE26/02/18
AZV Selected by Magnet Group as Nursecall providerPRICE SENSITIVE15/02/18
AZV Results of Annual General Meeting29/11/17
AZV CEO's AGM address29/11/17
AZV Chairman's AGM address29/11/17
AZV Notice of Annual General Meeting/Proxy Form27/10/17
AZV Change in substantial holding06/10/17
AZV Appendix 4G - Corporate governance disclosures02/10/17
AZV Annual Report to shareholders02/10/17
AZV Change in substantial holding15/09/17
AZV Preliminary Final ReportPRICE SENSITIVE31/08/17
AZV Launches Mobile Apps19/07/17
AZV New hospital project in Nth AmericaPRICE SENSITIVE12/07/17
AZV Change of Director's Interest Notice21/06/17
AZV New hospital project in Saudi ArabiaPRICE SENSITIVE05/04/17
AZV Change of Directors interest notices24/03/17
AZV Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
AZV Becoming a substantial holder22/02/17
AZV Austco launches Pulse RTLSPRICE SENSITIVE30/01/17
AZV Appendix 3B10/01/17
AZV Completion of Rights Issue and Notice of Shortfall06/01/17
AZV Change of Director's Interest Notice03/01/17
AZV Completion of CellGuard business sale23/12/16
AZV Dispatch of Rights Offer documents07/12/16
AZV Change in substantial holding05/12/16
AZV Change in substantial holding from AEF30/11/16
AZV Cleansing Notice Placement30/11/16
AZV Rights issue notice to shareholders30/11/16
AZV Results of Meeting24/11/16
AZV 2016 AGM CEO's address24/11/16
AZV 2016 AGM Chairman's address24/11/16
AZV Appendix 3B Rights and Placement24/11/16
AZV Cleansing notice Rights offer24/11/16
AZV Rights Issue OfferPRICE SENSITIVE24/11/16
AZV Completion of Placement and Rights Issue offerPRICE SENSITIVE24/11/16
AZV Trading HaltPRICE SENSITIVE23/11/16
AZV New mental health unit project New ZealandPRICE SENSITIVE17/11/16
AZV Investor presentation16/11/16
AZV Sale of CellGuard businessPRICE SENSITIVE07/11/16
AZV Notice of Annual General Meeting/Proxy Form-AZV.AX 24/10/16
AZV Appendix 4G - Corporate Governance Disclosures-AZV.AX 26/09/16
AZV Full Year Statutory Accounts-AZV.AX 26/09/16
AZV New hospital project in Nth America-AZV.AX PRICE SENSITIVE30/08/16
AZV Full year results - Preliminary Final Report-AZV.AX PRICE SENSITIVE29/08/16
AZV Change of Director's Interest Notice-AZV.AX 08/07/16
AZV Change of Director's Interest Notice-AZV.AX 07/07/16
AZV 2016 Guidance-AZV.AX PRICE SENSITIVE02/06/16
AZV Investor Presentation-AZV.AX 13/04/16
AZV Half Yearly Report and AccountsPRICE SENSITIVE24/02/16
AZV Launch of Tacera Pulse software platform24/02/16
AZV Change in substantial holding07/12/15
AZV Change in substantial holding from AEF03/12/15
AZV Results of Meeting30/11/15
AZV CEO's Address to Shareholders30/11/15
AZV Chairman's Address to Shareholders30/11/15
AZV Notice of Annual General Meeting/Proxy Form30/10/15
AZV Final Directors Interest Notice x228/10/15
AZV Initial Directors Interest Notices22/10/15
AZV Appointment and resignation of Directors21/10/15
AZV Resignation of Chairman and Appendix 3Z12/10/15
AZV 2015 Annual report commentary25/09/15
AZV Annual Report to shareholders25/09/15
AZV Appendix 4G25/09/15
AZV Revised Securities Trading Policy22/09/15
AZV Preliminary Final ReportPRICE SENSITIVE27/08/15
AZV Initial Director's Interest Notice03/08/15
AZV Appendix 3B - Issue of options03/08/15
AZV Appointment of new CEOPRICE SENSITIVE31/07/15
AZV Change in substantial holding from AEF22/07/15
AZV Investor Relations Presentation
25/03/19
AZV Forfeiture and Issue of Options and Appendix 3B
20/03/19
AZV Azure HY19 Results Investor Presentation
27/02/19PRICE SENSITIVE
AZV Azure HY19 Results ASX and Media Release
27/02/19PRICE SENSITIVE
AZV Azure HY19 Appendix 4D and Interim Financial Report
27/02/19PRICE SENSITIVE
AZV Forfeiture of Options
04/02/19
AZV Change of Director's Interest Notice - Glenning
20/12/18
AZV Resignation of Company Secretary
03/12/18
AZV Results of Meeting
28/11/18
AZV CEO's Address to Shareholders
28/11/18PRICE SENSITIVE
AZV Chairman's Address to Shareholders
28/11/18PRICE SENSITIVE
AZV Market Update Impact of US Tariff Changes
28/11/18PRICE SENSITIVE
AZV Change of Director's Interest Notice - Astles
23/11/18
AZV Notice of Annual General Meeting/Proxy Form
26/10/18
AZV New Chief Financial Officer Joins Azure Healthcare
22/10/18
AZV Appendix 4G - Key to disclosures
28/09/18
AZV Full Year Statutory Accounts
27/09/18
AZV Change in substantial holding
14/09/18
AZV Ceasing to be a substantial holder
13/09/18
AZV Change in substantial holding
12/09/18
AZV Initial Director's Interest Notice
10/09/18
AZV Investor presentation - 2018 Results
03/09/18PRICE SENSITIVE
AZV New Director appointment
31/08/18
AZV 2018 Financial year results
29/08/18
AZV Preliminary Final Report
29/08/18PRICE SENSITIVE
AZV $1.9m new hospital project in Nth America
16/08/18PRICE SENSITIVE
AZV Agreement with Ideacom Mid-America Cements US position
31/07/18PRICE SENSITIVE
AZV Corporate Governance Statement
20/06/18 download Created with Sketch. 464.58KB
AZV Change of auditors
31/05/18 download Created with Sketch. 91.62KB
AZV New hospital project in Nth America
29/05/18PRICE SENSITIVE download Created with Sketch. 77.66KB
AZV FY18 Half year shareholders presentation
27/02/18
AZV Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE
AZV Selected by Magnet Group as Nursecall provider
15/02/18PRICE SENSITIVE
AZV Results of Annual General Meeting
29/11/17
AZV CEO's AGM address
29/11/17
AZV Chairman's AGM address
29/11/17
AZV Notice of Annual General Meeting/Proxy Form
27/10/17
AZV Change in substantial holding
06/10/17
AZV Appendix 4G - Corporate governance disclosures
02/10/17
AZV Annual Report to shareholders
02/10/17
AZV Change in substantial holding
15/09/17
AZV Preliminary Final Report
31/08/17PRICE SENSITIVE
AZV Launches Mobile Apps
19/07/17
AZV New hospital project in Nth America
12/07/17PRICE SENSITIVE
AZV Change of Director's Interest Notice
21/06/17
AZV New hospital project in Saudi Arabia
05/04/17PRICE SENSITIVE
AZV Change of Directors interest notices
24/03/17
AZV Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
AZV Becoming a substantial holder
22/02/17
AZV Austco launches Pulse RTLS
30/01/17PRICE SENSITIVE
AZV Appendix 3B
10/01/17
AZV Completion of Rights Issue and Notice of Shortfall
06/01/17
AZV Change of Director's Interest Notice
03/01/17
AZV Completion of CellGuard business sale
23/12/16
AZV Dispatch of Rights Offer documents
07/12/16
AZV Change in substantial holding
05/12/16
AZV Change in substantial holding from AEF
30/11/16
AZV Cleansing Notice Placement
30/11/16
AZV Rights issue notice to shareholders
30/11/16
AZV Results of Meeting
24/11/16
AZV 2016 AGM CEO's address
24/11/16
AZV 2016 AGM Chairman's address
24/11/16
AZV Appendix 3B Rights and Placement
24/11/16
AZV Cleansing notice Rights offer
24/11/16
AZV Rights Issue Offer
24/11/16PRICE SENSITIVE
AZV Completion of Placement and Rights Issue offer
24/11/16PRICE SENSITIVE
AZV Trading Halt
23/11/16PRICE SENSITIVE
AZV New mental health unit project New Zealand
17/11/16PRICE SENSITIVE
AZV Investor presentation
16/11/16
AZV Sale of CellGuard business
07/11/16PRICE SENSITIVE
AZV Notice of Annual General Meeting/Proxy Form-AZV.AX
24/10/16
AZV Appendix 4G - Corporate Governance Disclosures-AZV.AX
26/09/16
AZV Full Year Statutory Accounts-AZV.AX
26/09/16
AZV New hospital project in Nth America-AZV.AX
30/08/16PRICE SENSITIVE
AZV Full year results - Preliminary Final Report-AZV.AX
29/08/16PRICE SENSITIVE
AZV Change of Director's Interest Notice-AZV.AX
08/07/16
AZV Change of Director's Interest Notice-AZV.AX
07/07/16
AZV 2016 Guidance-AZV.AX
02/06/16PRICE SENSITIVE
AZV Investor Presentation-AZV.AX
13/04/16
AZV Half Yearly Report and Accounts
24/02/16PRICE SENSITIVE
AZV Launch of Tacera Pulse software platform
24/02/16
AZV Change in substantial holding
07/12/15
AZV Change in substantial holding from AEF
03/12/15
AZV Results of Meeting
30/11/15
AZV CEO's Address to Shareholders
30/11/15
AZV Chairman's Address to Shareholders
30/11/15
AZV Notice of Annual General Meeting/Proxy Form
30/10/15
AZV Final Directors Interest Notice x2
28/10/15
AZV Initial Directors Interest Notices
22/10/15
AZV Appointment and resignation of Directors
21/10/15
AZV Resignation of Chairman and Appendix 3Z
12/10/15
AZV 2015 Annual report commentary
25/09/15
AZV Annual Report to shareholders
25/09/15
AZV Appendix 4G
25/09/15
AZV Revised Securities Trading Policy
22/09/15
AZV Preliminary Final Report
27/08/15PRICE SENSITIVE
AZV Initial Director's Interest Notice
03/08/15
AZV Appendix 3B - Issue of options
03/08/15
AZV Appointment of new CEO
31/07/15PRICE SENSITIVE
AZV Change in substantial holding from AEF
22/07/15
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.